EW:NYSE
Edwards Lifesciences Corp
US$85,94
arrow_upward
+0,88%(+0,75) 1 HR
2 Okt, 11.39.13 GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk EW...
Pembukaan
US$85,52
Tinggi
US$86,48
Rendah
US$84,66
Kapitalisasi pasar
49,54 M
Volume rata-rata
3,23 jt
Volume
505,93 rb
Rasio P/E
49,72
Harga tinggi dalam 52 minggu terakhir
US$96,29
Harga rendah dalam 52 minggu terakhir
US$72,30
EPS
US$1,73
Beta
0,87
Saham beredar
576,40 jt
Jumlah karyawan
16 rb
Pembukaan
US$85,52
Tinggi
US$86,48
Rendah
US$84,66
Kapitalisasi pasar
49,54 M
Volume rata-rata
3,23 jt
Volume
505,93 rb
Rasio P/E
49,72
Harga tinggi dalam 52 minggu terakhir
US$96,29
Harga rendah dalam 52 minggu terakhir
US$72,30
EPS
US$1,73
Beta
0,87
Saham beredar
576,40 jt
Jumlah karyawan
16 rb
Artikel berita
Dari sumber web dan partner berita
Benzinga
·
53 menit yang lalu
Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve
Benzinga
·
7 jam yang lalu
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
News Corp
·
18 jam yang lalu
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day
Business Wire
·
19 jam yang lalu
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Tentang Edwards Lifesciences Corp
CEO-
Karyawan16 rb
Didirikan1958
Kantor PusatIrvine, California, Amerika Serikat
Sektor-
Situsedwards.com